Lecture 1: Congenital Anomalies of the Kidney and Urinary Tract (CAKUT)

1. Embryology of Kidney and Ureter

• Develops from Intermediate Mesoderm and passes through 3 stages:
• 1. Pronephros: Appears in 3rd week, nonfunctional, regresses by 5th week.
• 2. Mesonephros: Functions transiently between weeks 4–8. Gives rise to Mesonephric (Wolffian) duct (contributes to male genital system: epididymis, vas deferens, seminal vesicles). Paramesonephric duct forms female system (uterus, fallopian tubes) while regressing in males. In BOTH sexes, the Mesonephric duct forms the ureters and renal collecting system.
• 3. Metanephros (Definitive Kidney): Appears end of 4th week. Derived from two sources:
  • Ureteric bud: Forms the collecting system (ureter, renal pelvis, calyces, collecting ducts).
  • Metanephric blastema: Forms nephrons.
• Urine production starts by week 10. Kidneys ascend from the sacral to the lumbar region between weeks 6 and 10.
• Genetic regulation involves several genes: PAX2, HNF1B, RET, GDNF.

2. Congenital Anomalies Classification

• Anomalies of Number: Bilateral Agenesis (incompatible with life). Unilateral Agenesis (1 in 1100). Supernumerary Kidney.
• Anomalies of Volume/Structure: Hypoplasia, Cystic diseases.
• Anomalies of Ascent: Simple Renal Ectopia (failed to ascend, e.g., pelvic kidney), Cephalic Ectopia, Thoracic Kidney.
• Anomalies of Form/Fusion:
  • Crossed Renal Ectopia with/without fusion.
  • Horseshoe Kidney: Most common example of renal fusion (0.25%). Male to Female 2:1. Joined at lower poles by midline parenchymal tissue (the isthmus). Ascent is obstructed by the Inferior Mesenteric Artery (IMA) at L3/L4. Normal rotation is prevented, so the renal pelvis lies anteriorly. Associated with Turner's, Trisomy 18, Vesicoureteral Reflux, UPJ obstruction, and Wilms tumors. Diagnosed via Ultrasound/IVU (calyces of lower pole point medially).
• Anomalies of Rotation: Malrotation (normal: calyces lateral, pelvis medial).
• Anomalies of Vasculature: Aberrant (originate from non-aorta/renal main), Accessory (2+ branches to same segment). Aneurysm, Fistula.
• Anomalies of Collecting System: Calyceal diverticulum, Megacalycosis, Bifid pelvis.

3. Cystic Kidney Diseases (High Yield)

• Autosomal Recessive Polycystic Kidney Disease (ARPKD):
  • Disease of infancy/childhood. Dilated collecting tubules form cysts in cortex and medulla.
  • Genetics: PKHD1 gene on Chromosome 6.
  • Features: Prenatal Oligohydramnios (<200ml) → obstructed labor/respiratory issues. Bright homogeneously hyperechogenic kidneys. ALWAYS associated with Congenital Hepatic Fibrosis. Fatal uremia in infants; portal hypertension in older children.
• Autosomal Dominant Polycystic Kidney Disease (ADPKD):
  • Most common inheritable renal cystic disease. Presents in adulthood (4th decade).
  • Genetics: PKD-1 gene (Chromosome 16) - 90%; PKD-2 gene (Chromosome 4) - 10%.
  • Features: End-stage renal disease (ESRD) around 50 yrs. Incidence of Renal Cell Carcinoma (RCC) is NOT higher than general population.
  • Associations: 10-30% have Berry aneurysms in Circle of Willis (Subarachnoid hemorrhage), cysts in liver (33%), pancreas (10%).
  • Treatment: Lipid-soluble antibiotics (Fluoroquinolones, Trimethoprim-sulfamethoxazole) for UTIs.
• Multicystic Dysplastic Kidney (MDCK):
  • Most common cystic disorder of infancy and 2nd most common cause of abdominal mass (after UPJO).
  • Pathology: Entire kidney is dysplastic. Haphazard distribution of cysts of various sizes without connections.
  • Diagnosis: Radioisotope scans (DMSA/MAG3) show NO renal uptake (unlike hydronephrosis). Unilateral disease associated with contralateral Vesicoureteral Reflux (18-43%) or UPJO.
• Simple Cysts: Confined to cortex. Single layer of flattened cuboidal epithelium. Do not communicate with nephron. Very common (>50% postmortem after age 50). CT typical density -10 to +20 Hounsfield Units, with no enhancement. Require no treatment if smooth/anechoic.
• Medullary Sponge Kidney (MSK): Dilatation of distal collecting ducts in medulla. IVU shows "Bristles on a brush" or "Bouquet of flowers / Bunches of grapes". Up to 50% have hypercalciuria. Normal renal function unless obstructed by stones.

💡 Hints (High-Yield Pearls for Lecture 1)

• Hint 1: The Metanephros is the definitive kidney; the Ureteric bud forms the collecting system, and the Metanephric blastema forms the nephrons.
• Hint 2: In a Horseshoe Kidney, normal ascent is halted by the Inferior Mesenteric Artery at L3/L4.
• Hint 3: ARPKD (Chromosome 6) is fatal in infancy and is strictly linked to Congenital Hepatic Fibrosis.
• Hint 4: ADPKD (Chromosomes 16 & 4) presents in adulthood and is associated with Berry Aneurysms.
• Hint 5: To differentiate MDCK from UPJO: MDCK has no connections between cysts and shows no uptake on DMSA/MAG3 scans, whereas UPJO shows peripheral cysts connecting to a central pelvis.

Lecture 2: Ureteropelvic Junction Obstruction (UPJO) & Vesicoureteral Reflux (VUR)

1. Ureteropelvic Junction Obstruction (UPJO)

• Definition: Restriction to urine flow from renal pelvis to ureter. Males > Females (5:2). Left > Right (5:2). Bilateral in 10-40%.
• Most common cause of an abdominal mass in infants.
• Congenital Causes: Intrinsic (defect in circular smooth muscle or collagen forming aperistaltic segment). Extrinsic (Aberrant crossing lower-pole vessel is the most common extrinsic cause).
• Secondary Causes: Severe Vesicoureteral Reflux (VUR) causing kinking.
• Associated Anomalies: UPJO is the most common anomaly in the opposite kidney.
• Diagnosis:
  • Ultrasound: Renal pelvis dilatation WITHOUT a dilated ureter.
  • Diuretic MAG3 Renography (with Furosemide): Definitive diagnostic test. Shows a 'rising' curve despite diuretic.
  • Pressure-Flow (Whitaker studies): Checks differential pressure between kidney and bladder.
• Surgical Treatment:
  • Indications: Symptomatic, split renal function <45%, Complicated, Massive hydronephrosis.
  • Endopyelotomy: Full-thickness incision using sharp knife or Holmium:YAG laser. Stented for 6 weeks.
  • Pyeloplasty: Dismembered pyeloplasty (Anderson-Hynes) is common (success 95%).
  • Nephrectomy: If split function is <10% or severe pyonephrosis.

2. Ureteral Anomalies

• Duplex System: Bifid system (ureters join at UPJ), Bifid ureters (join distally but proximal to bladder), Double ureters (empty separately, complete duplication).
• Ectopic Ureter: Terminates caudally. Classic symptom in girls: Continuous incontinence with an otherwise normal voiding pattern. Boys: no incontinence, presents as recurrent orchitis.
• Ureteroceles:
  • Cystic dilatation of terminal ureter between layers of trigone. Females to Male (4:1). 80% arise from upper poles of duplicated systems.
  • Etiology: Delayed/incomplete canalization of the ureteral bud.
  • Diagnosis: IVU demonstrates classic Cobra-head (or spring-onion) deformity. Cystography shows a smooth, broad-based filling defect near trigone.
  • Treatment: Endoscopic incision at base or excision and reimplantation.

3. Vesicoureteral Reflux (VUR)

• Retrograde flow of urine from bladder to upper urinary tract. Overall incidence 10%, but found in up to 70% of infants with UTIs. 85% occurs in females. High grade/bilateral is more common in boys.
• Most common inherited anomaly of the genitourinary tract.
• Pathophysiology: Normal intramural ureter length to diameter ratio is 5:1. Primary VUR is due to congenital deficiency of longitudinal muscle (ratio <5:1). Usually resolves spontaneously as bladder grows.
• Secondary VUR Causes: Bladder outlet obstruction (BPH, Posterior urethral valves), detrusor hyperreflexia, iatrogenic (TURBT), inflammation (TB, Schistosomiasis).
• Diagnosis:
  • Voiding Cystourethrography (VCUG): Definitive test.
  • Radionuclide cystogram (RNC): 1% radiation exposure of VCUG, greater sensitivity for grades 2-5, ideal for screening/follow-up.
  • 99mTc-DMSA: Used to assess renal cortical scarring.
• International Classification System (VCUG):
  • Grade I: Contrast into non-dilated ureter.
  • Grade II: Into renal pelvis/calyces; no dilatation.
  • Grade III: Mild dilatation of ureter, pelvis, calyces.
  • Grade IV: Dilated and slightly tortuous ureter; moderate blunting of calyces.
  • Grade V: Severe ureteric dilatation, gross tortuosity, loss of papillary impressions.
• Management: Prophylactic antibiotics, timed voids. Surgical: Breakthrough UTIs, noncompliance, new renal scars, persistent reflux at puberty. Endoscopic treatment utilizes Dextranomer hyaluronic copolymer (Deflux) or PTFE.

💡 Hints (High-Yield Pearls for Lecture 2)

• Hint 1: UPJO diagnosis requires an ultrasound showing a dilated pelvis but a normal/non-dilated ureter.
• Hint 2: The gold standard imaging to confirm UPJO and test split function is Diuretic MAG3 Renography.
• Hint 3: A female child with continuous wetness but normal periodic voiding habits almost certainly has an Ectopic Ureter.
• Hint 4: VUR naturally tends to resolve as the child grows because the intravesical segment of the ureter elongates to reach the normal 5:1 ratio.
• Hint 5: Grade 5 VUR is specifically distinguished by severe tortuosity and the complete loss of papillary impressions.

Lecture 3: Renal and Ureteric Injuries

1. Renal Trauma

• Kidneys are the most commonly injured genitourinary organs (10% of all trauma cases). Blunt trauma is more common (RTAs, falls) and usually treated conservatively (5-10% major). Penetrating trauma (70% major) often requires exploration.
• Investigations: Contrast-enhanced CT is the GOLD STANDARD. If unexpected during immediate laparotomy, a One-shot IVP is used.
• Indications for Imaging:
  • Penetrating trauma if hemodynamically stable.
  • Rapid deceleration blunt trauma.
  • ALL blunt trauma with GROSS hematuria.
  • ALL blunt trauma with Microhematuria AND Hypotension (<90 mm Hg).
  • Pediatric patients with >5 RBCs/HPF.
• Classification (AAST by CT):
  • Grade I: Contusion (Micro/gross hematuria, normal studies) or Subcapsular nonexpanding hematoma without laceration.
  • Grade II: Nonexpanding perirenal hematoma, cortical laceration <1 cm depth without extravasation.
  • Grade III: Cortical laceration >1 cm depth without collecting system rupture/extravasation.
  • Grade IV: Laceration through cortex, medulla, and collecting system; OR Main renal artery/vein injury with contained hemorrhage.
  • Grade V: Completely shattered kidney OR Avulsion of renal hilum (devascularizing).
• Management:
  • Nonoperative: Standard for stable Grades I-III (and carefully staged IV/V).
  • Absolute Operative Indications: Hemodynamic instability/shock, Expanding/pulsatile hematoma, suspected vascular pedicle avulsion (Grade V), UPJ disruption.

2. Ureteral Injuries

• Causes: Blunt trauma is very rare (hyperextension of spine). Surgical trauma during pelvic surgery (gynecologic, obstetric, general, urologic) is the MOST COMMON cause. Preoperative catheterization makes them easier to protect.
• Imaging: Retrograde Ureterogram is the most sensitive test. Intraoperatively: one-shot IVP / CT.
• Methods of Treatment:
  • Upper Ureteral: Ureteroureterostomy (end-to-end), Ureterocalycostomy, Bowel interposition.
  • Mid Ureteral: Ureteroureterostomy, Transureteroureterostomy.
  • Lower Ureteral: Ureteroneocystostomy (reimplant into bladder), Psoas hitch of bladder, Boari flap operation.

💡 Hints (High-Yield Pearls for Lecture 3)

• Hint 1: Always order a Contrast-enhanced CT in a patient with blunt abdominal trauma who has Gross Hematuria.
• Hint 2: Microscopic hematuria only requires a CT if the patient also experienced Hypotension (<90 mmHg) at any point.
• Hint 3: The primary distinction between Grade II and Grade III renal trauma is a laceration depth of <1 cm vs >1 cm.
• Hint 4: An expanding or pulsatile hematoma is an absolute indication for emergency surgical exploration.
• Hint 5: Lower ureteral injuries sustained during pelvic surgery (like hysterectomy) are optimally repaired using Ureteroneocystostomy or a Psoas hitch.

Lecture 4: Urinary Diversion and Fistulae

1. Urinary Diversion

• Definition: Rerouting normal flow of urine out of the body. Can be Temporary/Permanent, Intubated/Non-intubated, Continent/Non-continent.
• Indications: Congenital anomalies, Spina bifida, Bladder Carcinoma (cystectomy), unrepairable fistulae, severe strictures.
• Kidney Methods: Nephrostomy (intubated), Pyelostomy (non-intubated).
• Ureter Methods: Cutaneous ureterostomy, Ileal conduit, Ureterosigmoidostomy, Metrofanov diversion.
• Bladder Methods: Suprapubic cystostomy (intubated), Vesicostomy (non-intubated, for bladder neck obstruction).
• Urethra: Urethrostomy.

2. Urinary Fistulae

• Abnormal communication. The primary cause is usually NON-urological.
• Intestino-Vesical Fistula:
  • Causes: Diverticulitis, Colonic cancer, Crohn's disease.
  • Symptoms: Vesical irritability, Pneumaturia (Gas) and Fecaluria (Feces per-urethra), constantly infected urine.
  • Treatment: Staged (Proximal colostomy -> closure -> closure colostomy) or Single stage resection.
• Ureterovaginal Fistula:
  • Clinical features: Dribbling of urine AND NORMAL VOIDING (because the unaffected ureter still fills the bladder).
  • Treatment: Re-implantation of the ureter.
• Vesicovaginal Fistula (VVF):
  • Etiology (Developing countries): Obstructed or prolonged childbirth, Schistosomiasis.
  • Etiology (Developed countries): Hysterectomy (75%), Pelvic surgery, Radiotherapy.
  • Symptoms: Immediate or delayed postoperative leakage from the vagina.
  • Examination: 3 swab test, Vaginal exam, Cystoscopy. Must do VCUG/IVU/CT because up to 12% have an associated ureteral injury.
  • Management: Small/early = conservative (catheter, antibiotics, anticholinergics). Large/late = Surgery (transabdominal or transvaginal).

💡 Hints (High-Yield Pearls for Lecture 4)

• Hint 1: Most urinary fistulae originate from non-urological primary diseases (like diverticulitis or gynecologic cancers).
• Hint 2: If a patient complains of passing gas or stool in their urine, suspect an Intestino-vesical fistula (likely from Diverticulitis or Crohn's).
• Hint 3: Ureterovaginal fistula hallmark: The patient leaks urine continuously from the vagina but still voids normally from the bladder.
• Hint 4: In developed countries, 75% of Vesicovaginal Fistulae (VVF) occur following a Hysterectomy.
• Hint 5: Always use the 3 Swab Test in a clinical setting to physically diagnose the location of a vaginal urinary fistula.

Lecture 5: Bladder Anatomy, Congenital & Acquired Diseases

1. Anatomy & Embryology

• Capacity: ~500 mL. Internal sphincter (smooth muscle, α-receptors). External sphincter (striated muscle, pudendal nerve).
• Blood supply: Superior/inferior vesical arteries (from internal iliac). Parasympathetic (S2-S4, cholinergic). Sympathetic (T10-L2).
• Histology: Transitional epithelium (3-7 layers). Detrusor muscle is randomly arranged, except at internal meatus where it has 3 layers (inner longitudinal, middle circular, outer longitudinal).
• Embryology: The bladder arises from the Urogenital Sinus (Endoderm). The Trigone is the only part derived from the Mesonephric ducts (Mesoderm). Allantois obliterates to form the Urachus (Median umbilical ligament).

2. Congenital Anomalies

• Bladder Exstrophy (Ectopia Vesicae):
  • Complete ventral defect. Posterior bladder wall lies exposed. 100% will have Vesicoureteral Reflux (VUR).
  • Classical Exstrophy: Always associated with Epispadias.
  • Cloacal Exstrophy: Failure of urorectal septum descent.
  • Bone defects: Diastasis (widening) of symphysis pubis causes a "waddling duck" gait.
  • Treatment: Staged reconstruction (Neonate closure -> Epispadias repair -> Bladder neck reconstruction). Cover the exposed bladder with plastic wrap (Saran wrap) to prevent sticking to diapers. Complications include Adenocarcinoma.
• Urachal Anomalies:
  • Patent Urachus (50%): Urine drains from umbilicus.
  • Urachal Cyst (30%): Low midline mass. Carries a risk of Adenocarcinoma at its vesical extremity.
• Congenital Bladder Diverticulum: Peak in boys <10 yrs. Located lateral and posterior to ureteral orifice. Smooth-walled. Often found in connective tissue diseases (Ehlers-Danlos, Menkes). VCUG is the gold standard.

3. Acquired Diseases

• Interstitial Cystitis (Hunner's ulcer): Middle-aged women. Fibrosis/loss of capacity. Represents a neuroimmunoendocrine disorder. NIDDK criteria requires Hunner's ulcer and Glomerulations (submucosal petechiae) on cystoscopy. Treatment: Oral Tricyclic Antidepressants, Sodium pentosan polysulfate, Hydrodistention.
• Schistosomiasis (Bilharzia):
  • Organism: Schistosoma haematobium (Egypt, Africa, Middle East). Parasite penetrates skin -> migrates to vesical veins -> lays eggs.
  • Stages: Swimmer's itch -> Katayama fever -> Active inflammation.
  • Symptoms: Terminal hematuria.
  • Diagnosis: Eggs with a terminal spine in urine. Radiography shows pathognomonic Calcified "fetal head" in the pelvis. IVU shows ureteral calcification (mural, dilated ureter).
  • Complications: Squamous Cell Carcinoma (SCC) of the bladder.
  • Medical Treatment: Praziquantel (drug of choice), Metrifonate, Niridazole.

💡 Hints (High-Yield Pearls for Lecture 5)

• Hint 1: The Trigone is the only part of the bladder derived from the Mesoderm (mesonephric ducts).
• Hint 2: A newborn with an exposed bladder (Classical Exstrophy) will almost invariably also have Epispadias.
• Hint 3: Keep an exposed exstrophic bladder moist using plastic wrap to prevent mucosal excoriation.
• Hint 4: Interstitial Cystitis classically presents with severe pain upon bladder filling, relieved by voiding, and cystoscopy reveals Hunner's ulcers.
• Hint 5: A calcified "fetal head" appearance in the pelvis on a plain radiograph is pathognomonic for chronic Schistosoma haematobium infection.

Lecture 6: Neurogenic Bladder & Voiding Dysfunction

1. Neurogenic Bladder & Spinal Shock

• Spastic Bladder: Upper Motor Neuron lesion (Above S2-S4). Hypertonic detrusor, reduced capacity.
• Flaccid Bladder: Lower Motor Neuron lesion (Involves S2-S4 or peripheral nerves). Hypotonic, low flow rates, large volume of residual urine.
• Spinal Shock: Immediate post-injury (lasts days to months). Detrusor cannot contract, causing severe overflow incontinence. Management: Aseptic intermittent catheterization to prevent upper tract damage and combat infection (high fluid intake 3L/day).

2. Urodynamics

• Postvoid Residual Volume (PVR): High volume indicates an emptying problem.
• Cystometrogram (CMG): Pressure/volume relationship during filling. Calculates Detrusor Pressure: Pdet = Pves - Pabd.
• Uroflowmetry: Rate of urine flow. Normal is a bell-shaped curve. Flattened/interrupted curve indicates obstruction or underactivity.
• Electromyography (EMG): Normally, the EMG is silent during voiding.
• Pressure-Flow Study (PFS): Differentiates between bladder outlet obstruction and detrusor underactivity.

3. Incontinence & Retention

• Urinary Retention: Acute (sudden, painful, <800ml), Acute on Chronic (>800ml), Chronic (painless, >300ml residual). Causes include BPH, Disc herniation, Anticholinergics. Management: Catheterization.
• Stress Incontinence: Leakage with increased intra-abdominal pressure (coughing) due to pelvic floor weakness (childbearing). Treatment: Kegel's exercises, α-agonists, topical estrogen, slings.
• Urge Incontinence: Uninhibited detrusor contraction causing unexpected strong urge. Treatment: Antispasmodics (Oxybutynin), Anticholinergics (Tolterodine), Tricyclic antidepressants (Imipramine).
• Overflow Incontinence: Loss when intravesical pressure exceeds urethral pressure (due to retention e.g., BPH).
• Total Incontinence: Constant loss without warning (fistulae, ectopic ureter).

4. Nocturnal Enuresis

• Involuntary loss of urine during sleep. Normal up to age 3. 15% of children have it at age 5. Males > Females. Primary (never dry >6mo) vs Secondary (relapse).
• Etiology: Delayed maturation, altered ADH secretion (nocturnal polyuria).
• Management:
  • Nonpharmacologic: Motivational therapy (positive reinforcement), Behavioral Conditioning (Signal Alarm Device - 70% success), Bladder-training.
  • Pharmacologic (>7 years old): Tricyclic Antidepressants (Imipramine), Anticholinergics (Oxybutynin), Desmopressin Acetate (DDAVP) synthetic ADH. Prognosis: 15% spontaneous resolution per year.

💡 Hints (High-Yield Pearls for Lecture 6)

• Hint 1: A lesion ABOVE the S2-S4 level causes a Spastic (hypertonic) bladder, whereas a lesion AT S2-S4 causes a Flaccid (hypotonic) bladder.
• Hint 2: True detrusor pressure during urodynamics is calculated by subtracting abdominal pressure from total vesical pressure (Pdet = Pves - Pabd).
• Hint 3: Stress Incontinence is managed with Kegel exercises, while Urge Incontinence is managed with Anticholinergics (Oxybutynin).
• Hint 4: The most effective non-pharmacologic treatment for nocturnal enuresis is the Signal Alarm Device.
• Hint 5: Desmopressin (DDAVP) is highly effective for enuresis caused by an altered ADH profile (nocturnal polyuria).

Lecture 7: Bladder Tumours & Injuries

1. Bladder Tumours: Pathology & Risk Factors

• 2nd most common urological cancer in USA, 1st in Iraq. Men > Women (3:1). Peaking in 8th decade.
• Types of Primary Malignancy:
  • Transitional Cell Carcinoma (TCC): 90%. Papillary (exophytic) vs Invasive (solid/broad base).
  • Carcinoma In Situ (CIS): 5%. Flat, velvet-like anaplasia, nonpapillary. Progresses very quickly.
  • Squamous Cell Carcinoma (SCC): 5-10%. Associated with chronic irritation (Schistosomiasis, stones, long-term catheters).
  • Adenocarcinoma: <2%. Often at the fundus/dome due to congenital urachal origin.
• Risk Factors:
  • Cigarette Smoking: #1 risk factor (50% in men). Secretion of alpha/beta-naphthylamines.
  • Occupational exposure: Aromatic amines, Aniline dyes (rubber/dye workers). Latent period 25-45 years.
  • Genetic: Loss of Chr 9, Deletion on Chr 11/17, c-Ha-ras overexpression, P53 mutation.
• Tumor Grading (WHO-ISUP): PUNLMP (Grade I), Low Grade (Grade II), High Grade (Grade III).

2. Staging & Diagnosis

• TNM Staging (High Yield):
  • Ta: Non-invasive papillary.
  • Tis: Carcinoma In Situ (flat).
  • T1: Invades subepithelial connective tissue. (Ta, Tis, T1 = Non-Muscle Invasive)
  • T2: Invades Muscularis Propria (detrusor). (T2+ = Muscle Invasive)
  • T3: Invades perivesical tissue (a: microscopic, b: macroscopic).
  • T4: Invades adjacent organs (prostate, uterus, vagina, pelvic wall).
• Presentation: Painless gross hematuria (~90%). Irritative symptoms (frequency, urgency) mostly occur with CIS. Bimanual Exam (EUA): T2 is palpable thickening, T3 is palpable mobile mass, T4 is fixed mass.
• Investigations:
  • Urine Cytology: Excellent for high-grade/CIS, poor for low-grade.
  • Tumor Markers: BTA, NMP22, Immunocyt, Telomerase, Flow Cytometry.
  • Cystourethroscopy and TURBT: Gold standard for diagnosis and initial staging. Fluorescence Cystoscopy (blue light with 5-ALA or Hexaminolevulinate HAL) emits red fluorescence for malignant lesions.

3. Treatment of Bladder Tumours

• Non-Muscle Invasive (Ta, Tis, T1):
  • TURBT is the initial step for all.
  • Intravesical BCG (Bacillus Calmette-Guérin): Most efficacious for CIS. Decreases recurrence AND progression. BCG Sepsis treated with Isoniazid, Rifampin, Ethambutol.
  • Intravesical Chemo: Mitomycin C (causes palmar/genital rash), Thiotepa (myelosuppression), Doxorubicin. Decreases recurrence only.
• Muscle Invasive (T2-T4):
  • Radical Cystectomy: Gold standard. Removal of anterior pelvic organs + bilateral node dissection.
  • Radiotherapy: For poor surgical candidates.
• Metastatic (Any T, N+, M1): Systemic Chemotherapy. MVAC regimen (Methotrexate, Vinblastine, Adriamycin, Cisplatin) or Gemcitabine.

4. Bladder Injuries

• Pelvic fracture accompanies bladder rupture in 90% of cases.
• Types:
  • Extraperitoneal (85%): Usually associated with pelvic fracture (bone spicule puncture).
  • Intraperitoneal (15%): Direct blow to a full bladder causing burst at the dome. Acute abdomen.
• Diagnosis: Bloody urethral discharge implies urethral injury → Do Urethrogram BEFORE catheterization. Cystography is key (must include a post-drainage film).
  • Extraperitoneal: Flame-shaped contrast collection.
  • Intraperitoneal: Contrast outlines loops of bowel.
• Treatment:
  • Extraperitoneal: Urethral catheter drainage only (~10 days).
  • Intraperitoneal: Immediate open surgical repair (transperitoneal approach).

💡 Hints (High-Yield Pearls for Lecture 7)

• Hint 1: Painless gross hematuria is the most common presentation (~90%) of bladder tumors.
• Hint 2: Cigarette smoking and occupational exposures (aniline dyes) are the top risk factors for Transitional Cell Carcinoma.
• Hint 3: Intravesical BCG is highly effective because it decreases both the recurrence AND progression of superficial tumors (especially CIS).
• Hint 4: Extraperitoneal bladder rupture shows a "flame-shaped" extravasation and is treated conservatively with a catheter.
• Hint 5: Intraperitoneal bladder rupture is a surgical emergency requiring immediate open repair.

Lecture 8: Key Comparisons (المقارنات الشاملة)

1. ARPKD vs ADPKD

Feature	ARPKD (Infantile)	ADPKD (Adult)
Genetics	PKHD1 (Chromosome 6)	PKD-1 (Chr 16) - 90%, PKD-2 (Chr 4)
Age of Onset	Infancy / Childhood	Adulthood (4th decade)
Clinical Presentation	Prenatal oligohydramnios, severe uremia, respiratory failure in neonates.	Hypertension, hematuria, flank pain, UTI, ESRD by age 50.
Associations	Congenital Hepatic Fibrosis (ALWAYS)	Berry Aneurysms (Circle of Willis), Hepatic cysts.

2. Multicystic Dysplastic Kidney (MDCK) vs UPJO Hydronephrosis

Feature	MDCK	UPJO (Hydronephrosis)
Pathology	Entire kidney is dysplastic.	Dilatation of renal pelvis due to obstruction.
Cyst Arrangement	Haphazard, NO visible connections between cysts.	Peripheral cysts connected to a central/medial cyst (pelvis).
Isotope Scan (MAG3/DMSA)	NO renal uptake (non-functioning).	Shows some function; isotope accumulates ('rising curve').

3. Ectopic Ureter: Boys vs Girls

Feature	Girls	Boys
Incontinence	Continuous incontinence despite normal voiding.	No incontinence (orifice is always above external sphincter).
Common Presentation	Constant wetness/dribbling.	Recurrent attacks of orchitis / epididymitis.

4. Vesicovaginal Fistula (VVF) vs Ureterovaginal Fistula

Feature	Vesicovaginal Fistula (VVF)	Ureterovaginal Fistula
Main Cause	Prolonged childbirth (developing), Hysterectomy (developed).	Surgical trauma during pelvic surgery (Hysterectomy).
Voiding Pattern	Continuous leakage, often inability to store urine.	Dribbling of urine AND Normal Voiding.
Diagnosis	Vaginal exam, 3 swab test.	IVU, Retrograde ascending catheterization.

5. Spastic vs Flaccid Neurogenic Bladder

Feature	Spastic Bladder	Flaccid Bladder
Lesion Location	Above S2-S4 (Upper Motor Neuron).	Involves S2-S4 or peripheral nerves (Lower Motor Neuron).
Bladder Tone	Hypertonic (overactive).	Hypotonic (flaccid).
Capacity & Flow	Reduced capacity.	Large volume of residual urine, low flow rates.

6. Types of Urinary Incontinence

Type	Mechanism / Cause	Treatment
Stress	Increased intra-abdominal pressure (cough) + weak pelvic floor.	Kegel exercises, α-agonists, Slings.
Urge	Uninhibited detrusor contraction / strong unexpected urge.	Anticholinergics (Oxybutynin, Tolterodine).
Overflow	Intravesical pressure exceeds urethral pressure (Retention/BPH).	Catheterization, treating underlying obstruction.

7. Extraperitoneal vs Intraperitoneal Bladder Rupture

Feature	Extraperitoneal Rupture (85%)	Intraperitoneal Rupture (15%)
Mechanism	Direct bone spicule puncture (associated with pelvic fracture).	Direct blow to a full bladder causing burst at the dome.
Cystography	Flame-shaped collection of contrast in the pelvis.	Contrast outlines the loops of bowel.
Treatment	Conservative: Urethral catheter drainage (~10 days).	Surgical: Immediate open surgical repair.

8. Non-Muscle Invasive vs Muscle Invasive Bladder Cancer

Feature	Non-Muscle Invasive	Muscle Invasive
TNM Stages	Ta, Tis (CIS), T1	T2, T3, T4
Initial Procedure	TURBT (Diagnostic and often therapeutic).	TURBT (for staging).
Definitive Treatment	Intravesical BCG (immunotherapy) or Chemotherapy (Mitomycin C).	Radical Cystectomy (+ Systemic Chemo if needed).